Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review

David Feldman1, Elizabeth Leahy1, Seong-Ho Lee1

  • 1Department of Nutrition and Food Science, College of Agriculture and Natural Resources, University of Maryland, College Park, MD 20742, United States.

Insights

Tolfenamic acid, a non-steroidal anti-inflammatory drug (NSAID), shows promise as an anti-cancer agent. Research highlights its molecular mechanisms and potential for combination therapy in cancer treatment.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID) traditionally used for inflammation, migraines, and pain.
  • Emerging evidence suggests tolfenamic acid exhibits anti-cancer properties, necessitating further investigation into its mechanisms.

Purpose of the Study:

  • To elucidate the cellular and molecular mechanisms underlying the anti-cancer activity of tolfenamic acid.
  • To explore the potential of tolfenamic acid as a therapeutic agent for cancer treatment.
  • To review the benefits of combining tolfenamic acid with other anti-cancer drugs.

Main Methods:

  • Analysis of gene expression changes induced by tolfenamic acid, focusing on cancer hallmarks.
  • Investigation of tolfenamic acid's impact on multiple oncogenic and tumor-suppressive signaling pathways in various cancer models.
  • Literature review and synthesis of existing research on tolfenamic acid's anti-cancer effects.

Main Results:

  • Tolfenamic acid alters gene expression related to apoptosis, growth arrest, angiogenesis, and metastasis.
  • The drug targets several key signaling pathways implicated in cancer development and progression.
  • Experimental data supports the anti-cancer potential of tolfenamic acid across different cancer types.

Conclusions:

  • Tolfenamic acid demonstrates multifaceted anti-cancer mechanisms by modulating critical cellular pathways.
  • Its ability to target multiple cancer hallmarks makes it a promising candidate for novel cancer therapies.
  • Combination therapy with tolfenamic acid and other anti-cancer agents may enhance treatment efficacy.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...